心血管疾病中的乳化:目前的进展和前景
Zhi-Mo Wang1, Qing-Wen Yu1, Cong Wang1
1Department of Pharmacology, School of Basic Medical Sciences Zhengzhou University Zhengzhou China.
Journal of the American Heart Association
|September 30, 2025
概括
乳化是一种新的表观遗传修饰,正在成为心血管疾病 (CVD) 的潜在因素. 需要进一步的临床研究,以了解其在心血管疾病发病过程中的作用,并开发新的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 人们越来越认识到表观遗传修饰,如乳糖化,对于它们在疾病中的作用.
- 乳化是一种翻译后的修饰,它会影响基因素和非基因素蛋白.
- 与乳糖化相关的过程,包括炎症和脂质代谢,在心血管疾病 (CVD) 的发展中至关重要.
研究的目的:
- 审查当前关于乳糖化和其在心血管疾病 (CVDs) 中潜在的参与的知识.
- 探索乳酸化在心血管疾病发病过程中的调节酶和功能性作用.
- 确定与心血管疾病中的乳糖化相关的治疗和诊断策略的未来研究方向.
主要方法:
- 对乳化前临床和新兴研究的文献综述.
- 通过乳化调节的生物化学途径的分析.
- 综合目前对乳糖化在心血管疾病中的功能影响的理解.
主要成果:
- 乳化会影响与心血管疾病相关的关键细胞过程,如炎症,脂质代谢和血管生成.
- 将乳糖化与心血管疾病联系在一起的证据主要来自临床前研究.
- 精确的机制连接乳酸和心血管疾病的发病需要进一步阐明.
结论:
- 乳化代表了对心血管疾病 (CVD) 的新研究领域.
- 了解乳化作用可能为心血管疾病诊断和治疗提供新的途径.
- 临床验证至关重要,以证实乳化在人类心血管疾病中的重要性.
相关概念视频
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Regulation of the Cardiovascular System
3.7K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Coronary Artery Disease II: Pathophysiology
374
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
374
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
361
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
361


